PubMed Health⌕ Search

Biomedical subjects

Ian Adatia

Publications and source records attributed to Ian Adatia.

23 records · Page 2Linked to original sources

Early mediastinal seroma secondary to modified Blalock-Taussig shunts--successful management by percutaneous drainage.

BACKGROUND: Large symptomatic mediastinal seroma following modified-BT shunts, traditionally required revisional thoracotomy. OBJECTIVE: We describe percutaneous image-guided pigtail catheter drainage in the successful treatment of early mediastinal seroma secondary to PTFE Blalock-Taussig shunt, avoiding thoracotomy. MATERIALS AND METHODS: A retrospective review of all relevant clinical and imaging records in five patients was performed. RESULTS: All five presented with intermittent stridor, respiratory distress and/or episodic desaturation within 6 weeks of their surgery. In four of five infants, percutaneous drainage was effective and reoperation was avoided. In one of five, rather than urgent surgical evacuation and BT shunt revision, we were able to perform an elective stage-II bidirectional Glenn SVC-RA anastamosis in a stable infant. There were no complications. CONCLUSIONS: Percutaneous image-guided drainage of mediastinal seroma secondary to PTFE-BT shunt is a safe, minimally invasive, and effective treatment. This may avoid BT shunt revision.

Cardiac Surgical Procedures↗

Levels of exhaled nitric oxide before and after surgical and transcatheter device closure of atrial septal defects in children.

OBJECTIVES: We have shown that exhaled nitric oxide levels decrease after surgical closure of congenital left-to-right cardiac shunts. It remains unclear whether the change in exhaled nitric oxide levels reflects endothelial injury caused by the use of cardiopulmonary bypass or the decrease in pulmonary blood flow attendant on shunt closure. Transcatheter atrial septal defect closure permits shunt closure without the use of cardiopulmonary bypass. Therefore we compared changes in exhaled nitric oxide levels after surgical and transcatheter device closure of atrial septal defects. METHODS: We enrolled sequentially 30 children undergoing atrial septal defect closure. Fifteen patients (age range, 0.4-16 years; median age, 6.5 years) underwent surgical atrial septal defect closure with cardiopulmonary bypass, and 15 patients (age range, 4-17 years; median age, 8.4 years) had device closure of the atrial septal defect in the catheterization laboratory. We measured nitric oxide levels in end-tidal expiratory gas with a rapid-response chemiluminescent analyzer before and after atrial septal defect closure. RESULTS: After surgical repair of the atrial septal defect, exhaled nitric oxide decreased by 21%, from 10.9 +/- 4.4 to 8.4 +/- 3.3 ppb (P <.005), whereas after transcatheter defect closure, exhaled nitric oxide increased by 23%, from 7.6 +/- 2.6 to 9.3 +/- 3.7 ppb (P <.005). Hemoglobin levels in patients undergoing surgical intervention were significantly lower (P =.0001) postoperatively. CONCLUSIONS: We confirmed that exhaled nitric oxide, despite a fall in hemoglobin, decreases after surgical closure of atrial septal defects. In contrast, exhaled nitric oxide levels increase after transcatheter closure. Exhaled nitric oxide levels may reflect bypass-induced endothelial cell injury and are independent of changes in pulmonary blood flow.

Adolescent↗

Recent advances in pulmonary vascular disease.

There have been remarkable advances in our understanding of the pathobiology of pulmonary hypertension. A region on chromosome 2 encoding bone morphogenetic receptor type 2 has been identified to underlie familial and many cases of sporadic primary pulmonary arterial hypertension. The vasoactive mediators, discovered and defined by vascular biologists, have been translated into promising treatments of human disease. Prostacyclin, endothelin receptor blockers, sildenafil, and nitric oxide have been applied therapeutically to limit, and occasionally reverse, the inexorable damage to the pulmonary circulation initiated by recently identified genetic and environmental triggers of pulmonary arterial hypertension.

Antihypertensive Agents↗

High-frequency oscillation in children after Fontan operation.

OBJECTIVE: The increase in intrathoracic pressure produced by positive-pressure ventilation has been shown to have an adverse effect on pulmonary blood flow after Fontan operations. OBJECTIVE: The main objective was to compare the hemodynamic effect of high-frequency oscillation ventilation (HFOV) with intermittent positive-pressure ventilation (IPPV) in children after Fontan operations. DESIGN: Prospective study. SETTING: Department of pediatric critical care in a tertiary care, university-based children's hospital. PATIENTS: Five children (age, 2.3 +/- 0.3 yrs) in the early period after Fontan operations. INTERVENTION: After a short period of stabilization after surgery using conventional IPPV, baseline data were collected and patients were converted to HFOV. After a short period of stabilization using HFOV, a second series of measurements were performed and patients were reconnected to IPPV, after which a third series of measurements were made. Paco(2) and pH were kept unchanged throughout the study. MEASUREMENTS AND MAIN RESULTS: Hemodynamic and respiratory variables were obtained at each time point (IPPV1, HFOV, and IPPV2). The mean cardiac index at baseline (IPPV1) was 3.1 +/- 1.1 L/min/m(2); during HFOV, it was 3.2 +/- 1.2 L/min/m(2) (p =.46); and during IPPV2, it was 3.1 +/- 1.1 L/min/m(2). The mean pulmonary vascular resistance values using IPPV1, HFOV, and IPPV2 were 3.0 +/- 1.1, 2.7 +/- 1.3 (p =.21), and 2.6 +/- 1.1 Woods units/m(2), respectively. CONCLUSION: HFOV had no effect on the cardiac output or the pulmonary vascular resistance in a small group of stable patients after Fontan operations.

Journal Article↗